CML28 Is a Broadly Immunogenic Antigen, Which Is Overexpressed in Tumor Cells

Donor lymphocyte infusion (DLI) reliably induces durable remission in 75–80% of patients with relapsed chronic myelogenous leukemia (CML) after allogeneic hematopoietic stem cell transplantation. To identify immunological targets of the graft-versus-leukemia response (GVL) after DLI, we used CML pos...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Res
Autori principali: Yang, Xiao-Feng, Wu, Catherine J., Chen, Linyun, Alyea, Edwin P., Canning, Christine, Kantoff, Philip, Soiffer, Robert J., Dranoff, Glenn, Ritz, Jerome
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2002
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4762257/
https://ncbi.nlm.nih.gov/pubmed/12359762
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi